Status:
RECRUITING
Prehabilitation for Ovarian Cancer Patients
Lead Sponsor:
Nova Scotia Health Authority
Collaborating Sponsors:
Dalhousie University
Conditions:
Prehabilitation
Exercise
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Individuals with ovarian cancer have very poor survival rates. This is because the cancer is not usually detected until it has reached advanced stages. How long an individual survives also is determin...
Eligibility Criteria
Inclusion
- 18 years or older
- Have a confirmed diagnosis of stage III or IV ovarian cancer
- Scheduled to receive cytoreductive surgery as part of their treatment plan
- Must have a minimum of 4-weeks between the time of study enrollment and scheduled surgery
- Be able to attend in-person and/or virtual exercise sessions
- Be fluent in English
- Have oncologist approval
Exclusion
- Have already completed surgery
- Unstable cardiac or respiratory disease, injury or any other co-morbid disease that may make it unsafe for participants to exercise
- Significant cognitive impairment (e.g., do not have the capacity to consent, unable to follow exercise instructions)
Key Trial Info
Start Date :
January 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05364879
Start Date
January 3 2023
End Date
August 31 2025
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Health
Halifax, Nova Scotia, Canada, B3L 4P1